Nitinol self-expanding stents (Endocoil-InSTENT) for palliative treatment of esophageal and esophago-gastric neoplastic obstruction. Preliminary experience

A. Lomazzi, C. Benenti, I. Merati, R. Rivolta, M. Dinelli, E. Cassina, L. Beretta

Research output: Contribution to journalArticlepeer-review

Abstract

Seven patients with neoplastic stenosis of esophagus (2 with recurrency after RT+CT, 1 with primary disease, 1 with diffuse breast cancer and 1 with recurrent lung Ca after surgery+RT) and cardia (1 squamous cells Ca involving cardia and 1 adenoCa of the cardia involving distal esophagus) not suitable for radical treatment, were submitted to intubation with Endocoil Nitinol self-expanding stents, InSTENT 16 mm or 18 mm final diameter/10 cm length (the residual diameter was in all patients less than 10 mm, range 5-9 mm). The intubation was successfull in all patients, with no need of previous dilation of more than 11 mm, no acute complications or migration and occlusion at follow-up, nor chest pain 24-48 hours after the procedure. All patients had prompt relief of dysphagia (mean score's reduction from 3.4 to 1). Average follow-up is 73 days (range 30-150 days): two patients died 30 and 150 days after the intubation for systemic progression of disease.

Original languageEnglish
Pages (from-to)47-50
Number of pages4
JournalGiornale Italiano di Endoscopia Digestiva
Volume19
Issue number1
Publication statusPublished - 1996

Keywords

  • endoscopic palliation
  • neoplasms of the esophagus and cardia
  • Nitinol Endocoil self-expanding stents

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Nitinol self-expanding stents (Endocoil-InSTENT) for palliative treatment of esophageal and esophago-gastric neoplastic obstruction. Preliminary experience'. Together they form a unique fingerprint.

Cite this